Every SEC Form 3/4/5 on record for this filer (CIK 1405104) — 5 issuers, 55 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc. | Director | 2020-10-15 → 2026-06-12 | 8 | — |
| RPRX | Royalty Pharma plc | Director | 2020-06-15 → 2026-06-08 | 11 | −$1M |
| ZTS | Zoetis Inc. | Director | 2016-02-22 → 2026-03-10 | 29 | −$972,315 |
| NSTG | NanoString Technologies Inc | Director · lapsed | 2016-01-05 → 2024-05-08 | 16 | −$872,192 |
| ETTX | Entasis Therapeutics Holdings Inc. | Director · lapsed | 2018-09-25 → 2019-06-21 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RPRX | 2026-05-14 | Sell | 3,045 | $53.00 | $161,385 | 191,803 |
| RPRX | 2025-08-11 | Sell | 33,500 | $36.23 | $1M | 194,848 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.